Hemodynamic instability during tracheal intubation in the intensive care unit may result from a predictable sequence of physiologic events that begins prior to induction and continues through postintubation care. A recent review highlighted prior evidence showing that cardiovascular instability complicates nearly 50% of intensive care unit intubations and described hypotension as the most common and consequential peri-intubation complication.
Investigators synthesized evidence from randomized trials, observational studies, physiologic investigations, and airway management literature involving patients with critical illness and focused on how hemodynamic status evolves during intubation, from pre-induction adrenergic surge through induction, apnea, positive-pressure ventilation, and postintubation management.
Among the studies, the INTUBE cohort demonstrated a cardiovascular instability rate of 43%, severe hypoxemia rate of 9%, and cardiac arrest rate of 3% among patients intubated in the intensive care unit (ICU). The review cited prior analyses showing that intubation-related hypotension was associated with increased ICU and 28-day mortality.
The investigators described many patients with critical illness as existing in a fragile physiologic equilibrium prior to intubation. Although blood pressure may appear normal or elevated, that stability may depend on an endogenous catecholamine surge that maintains cardiac output and vascular tone. According to the investigators, induction agents can abruptly blunt that sympathetic compensation and expose underlying circulatory vulnerability.
Prior studies cited in the review associated propofol with hypotension through systemic vasodilation and myocardial depression. INTUBE analyses identified propofol as a modifiable risk factor for cardiovascular collapse. Ketamine and etomidate generally demonstrated greater hemodynamic tolerance, although comparative evidence remained mixed.
The investigators highlighted a recent multicenter randomized trial of 2,365 patients with critical illness that compared ketamine with etomidate for rapid-sequence induction. While 28-day mortality did not differ significantly between the groups, cardiovascular collapse occurred in 22% of the patients receiving ketamine compared with 17% of those receiving etomidate.
Beyond induction, the investigators described apnea as an additional source of physiologic stress. Progressive hypoxemia, hypercapnia, and acidosis may impair myocardial contractility, reduce responsiveness to catecholamines, and increase arrhythmia risk. Patients with acute respiratory distress syndrome, pulmonary embolism, or other causes of impaired oxygenation such as aspiration may be particularly susceptible to these effects.
The transition to positive-pressure ventilation may further worsen hemodynamic status. Increased intrathoracic pressure can reduce venous return and increase right ventricular afterload, particularly among patients with acute respiratory distress syndrome and pulmonary vascular dysfunction. The investigators noted that positive end-expiratory pressure can substantially affect cardiovascular function and suggested cautious titration during initial ventilator management.
The investigators summarized evidence supporting several preventive strategies. A network meta-analysis discussed in the review found that noninvasive ventilation reduced hypoxemia compared with high-flow nasal cannula and facemask oxygen, particularly among patients with severe oxygenation impairment. They highlighted evidence supporting videolaryngoscopy as a first-line approach because of its ability to improve first-pass success and cause fewer airway-related complications.
With respect to hemodynamic optimization, the investigators stated that a routine fluid bolus prior to intubation is not supported by the available evidence. Instead, they emphasized individualized assessment of fluid responsiveness and fluid tolerance. They also discussed ongoing randomized trials evaluating preemptive vasopressor infusions as a strategy to reduce peri-intubation cardiovascular instability.
The review's conclusions are limited by its design. As a narrative review, it did not generate new patient-level data or perform a quantitative meta-analysis. The investigators noted that randomized evidence remains limited for several proposed interventions, including preemptive vasopressor therapy and other approaches to peri-intubation hemodynamic optimization.
"Tracheal intubation in the ICU is a hemodynamic intervention with predictable, phase-specific vulnerabilities," wrote lead study author Yuki Kotani, of the Department of Intensive Care Medicine at the Kameda Medical Center in Japan, and colleagues. The investigators concluded that clinical decision-making should be guided by a mechanistic and pathophysiologic understanding and proactive bedside management while additional evidence emerges.
The study authors reported no competing interests and no funding.
Source: Journal of Intensive Care
